[{"text": "Thank you - that is very good to know! That is somewhat different from how the FDA has portrayed it, and I will keep it in mind for future stories", "timestamp": "08:41 - 23. M\u00e4rz 2019", "retweet_count": "0", "favorite_count": "0", "author": "sashachavkin", "is_retweet": true}, {"text": "Got it, thanks. Do you know if that is what happened in all 24 of the cases the FDA has recorded as smooth-surfaced? If so it seems like that is something the FDA should state publicly...", "timestamp": "08:26 - 23. M\u00e4rz 2019", "retweet_count": "0", "favorite_count": "0", "author": "sashachavkin", "is_retweet": true}, {"text": "Thanks for the note. My understanding has been different - for example, the FDA letter to health providers below says \"there are known cases in patients w smooth surfaced implants.\" Did those patients also have textured implants?\nhttps://www.fda.gov/medicaldevices/safety/letterstohealthcareproviders/ucm630863.htm \u2026", "timestamp": "08:14 - 23. M\u00e4rz 2019", "retweet_count": "0", "favorite_count": "0", "author": "sashachavkin", "is_retweet": true}, {"text": "FDA hearings on breast implant safety start Monday. We wrote an explainer to give straight facts on a key issue that the FDA & regulators worldwide are struggling to answer - whether textured breast implants are safe #ImplantFiles", "timestamp": "10:50 - 22. M\u00e4rz 2019", "retweet_count": "7", "favorite_count": "4", "author": "sashachavkin", "is_retweet": true}, {"text": "The Italian government takes action in response to the #ImplantFiles, including creating a registry for breast implants", "timestamp": "06:59 - 22. M\u00e4rz 2019", "retweet_count": "1", "favorite_count": "5", "author": "sashachavkin", "is_retweet": true}, {"text": "The full meeting materials, including a detailed agenda & FDA summary of the evidence, are here. I will be covering the hearings live on Twitter and also at http://icij.org  - send me any questions, thoughts or info that we should consider!\nhttps://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/GeneralandPlasticSurgeryDevicesPanel/ucm632855.htm?utm_source=CDRHTwitterD \u2026", "timestamp": "14:06 - 21. M\u00e4rz 2019", "retweet_count": "2", "favorite_count": "2", "author": "sashachavkin", "is_retweet": true}, {"text": "The panel is a group of FDA-selected experts who will then make recommendations after the hearing. These recs often guide policy but the FDA is not required to follow them", "timestamp": "14:01 - 21. M\u00e4rz 2019", "retweet_count": "0", "favorite_count": "0", "author": "sashachavkin", "is_retweet": true}, {"text": "The FDA posts meeting materials for next week's hearing on breast implant safety. Among the questions the panel will consider are risk factors for BIA-ALCL, risk profile of textured implants and how to address breast implant illness symptoms #ImplantFiles", "timestamp": "13:57 - 21. M\u00e4rz 2019", "retweet_count": "10", "favorite_count": "9", "author": "sashachavkin", "is_retweet": true}, {"text": "And 2) The main oversight changes he has set in motion are revising 510k process to ensure better predicate devices and moving towards active surveillance using electronic health records. Medical device discussion starts at about 10:30", "timestamp": "09:10 - 21. M\u00e4rz 2019", "retweet_count": "5", "favorite_count": "4", "author": "sashachavkin", "is_retweet": true}, {"text": "Interesting exit interview w FDA Commissioner @SGottliebFDA. He says 1) Medical device oversight has basically worked except for a \"small subset\" of devices, mostly for women's health (1/2)", "timestamp": "09:07 - 21. M\u00e4rz 2019", "retweet_count": "15", "favorite_count": "12", "author": "sashachavkin", "is_retweet": true}, {"text": "The #ImplantFiles wins the @opcofamerica award for best investigation! Grateful to our partners at @avrotrosradar, NBC News, the AP and across the world who made this project a reality ", "timestamp": "14:20 - 20. M\u00e4rz 2019", "retweet_count": "8", "favorite_count": "27", "author": "sashachavkin", "is_retweet": true}, {"text": "More news on breast implant oversight: the FDA sends warning letters to breast implant manufacturers Mentor and Sientra for failing to meet post-approval study requirements #ImplantFiles\nhttps://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm633890.htm \u2026", "timestamp": "14:18 - 19. M\u00e4rz 2019", "retweet_count": "10", "favorite_count": "11", "author": "sashachavkin", "is_retweet": true}, {"text": "\"This may be a long-awaited moment of validation for tens of thousands of women who have been brushed off\" - NY Times reports on the FDA reconsidering breast implant illness, after months of #ImplantFiles coverage from ICIJ", "timestamp": "14:13 - 19. M\u00e4rz 2019", "retweet_count": "20", "favorite_count": "26", "author": "sashachavkin", "is_retweet": true}, {"text": "A story with big implications: Kenyan court strikes down tax treaty with Mauritius, the favored tax haven for much of Africa. This is a major way that Africa's wealth gets plundered - kudos to @WillFitzgibbon for covering it relentlessly", "timestamp": "11:21 - 18. M\u00e4rz 2019", "retweet_count": "2", "favorite_count": "2", "author": "sashachavkin", "is_retweet": true}, {"text": "Significant news stories from Saudi Arabia: \nMore evidence of MBS's calculated brutality - he authorized a death squad to target dissenters\nhttps://www.nytimes.com/2019/03/17/world/middleeast/khashoggi-crown-prince-saudi.html \u2026\nMBS appears to have been stripped, at least temporarily, of some authority", "timestamp": "07:23 - 18. M\u00e4rz 2019", "retweet_count": "0", "favorite_count": "0", "author": "sashachavkin", "is_retweet": true}, {"text": "I think the biggest issue is whether patients are informed about the risks. Many women I've spoken with say they would have made different choices if they had been told before getting implants about breast implant illness and ALCL. But they weren't informed.", "timestamp": "07:02 - 18. M\u00e4rz 2019", "retweet_count": "0", "favorite_count": "2", "author": "sashachavkin", "is_retweet": true}, {"text": "This from the FDA stands out in particular: \"We believe the current evidence, although limited, suggests some individuals may be predisposed to develop an immune/inflammatory reaction when exposed to select materials.\"", "timestamp": "06:56 - 18. M\u00e4rz 2019", "retweet_count": "6", "favorite_count": "6", "author": "sashachavkin", "is_retweet": true}, {"text": "Perhaps most striking is the change in the FDA's tone on breast implant illness, which just a few months ago it strongly suggested did not exist. Now it says it needs more info to communicate risk and minimize harm\nhttps://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm633602.htm \u2026", "timestamp": "06:53 - 18. M\u00e4rz 2019", "retweet_count": "9", "favorite_count": "8", "author": "sashachavkin", "is_retweet": true}, {"text": "The FDA says it will investigate adverse patient reactions to silicone in breast implants, nickel in Essure, and other materials in medical devices. Significant new response to key issues in #ImplantFiles \nhttps://www.icij.org/investigations/implant-files/us-to-investigate-health-impact-of-nickel-silicone-in-medical-implants/ \u2026", "timestamp": "06:51 - 18. M\u00e4rz 2019", "retweet_count": "28", "favorite_count": "34", "author": "sashachavkin", "is_retweet": true}]